Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on ScCR Oxidoreductase. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102154377B reveals ScCR enzyme for asymmetric reduction. Enables cost-effective manufacturing of pharmaceutical intermediates with self-regenerating cofactors.